Enterobacteriaceae Infections Clinical Trial
— NeoLICOfficial title:
Neonatal Acquisition of ESBL-PE in a Low-income Country
NCT number | NCT04836208 |
Other study ID # | 2020-059 |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | April 30, 2021 |
Est. completion date | May 2023 |
Enterobacteriaceae, more specifically Escherichia coli and Klebsiella pneumoniae, are the bacteria most often responsible for neonatal infections in low-income countries. Infections caused by multidrug-resistant Enterobacteriaceae: Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E), are more often associated with an unfavorable outcome of the infection. Enterobacteriaceae colonize the digestive tract which is the first step in developing a potential infection. Very few studies have been carried out at the community level. Colonization of the mother with ESBL-E is generally considered to be a major route of acquisition. The carrying of ESBL-E by other family members and other potential sources of transmission (food, objects and surfaces in contact with the newborn) have never been documented. In addition, with a view to offering an intervention adapted to the local context, the local cultural determinants which govern the interactions of the newborn with his environment are important to understand.
Status | Recruiting |
Enrollment | 600 |
Est. completion date | May 2023 |
Est. primary completion date | May 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | N/A and older |
Eligibility | Inclusion Criteria: 1. For the epidemiological study : All members of 60 households in which a newborn baby has just been born Inclusion criteria for the mother at the time of childbirth, pregnant woman : _ having a monofetal pregnancy - residing regularly in the study area OR planning to reside in the study area during the study period; - having been informed of the research and collection of biological samples on herself and her newborn; - having given its agreement to carry out the research and the associated collection of biological samples, and; - having signed the informed consent (or its witness if applicable). Inclusion criteria for the live newborn at the time of childbirth, new born : - living after childbirth; - whose parents or legal representatives present: - reside regularly in the study area or plan to reside in the study area during the study period; - were informed of the research and the associated collection of biological samples on their newborn; - have given their agreement to carry out the research and the associated collection of biological samples, Inclusion criteria for the household member, resident: - from the same household as the mother-child (ren) couple included - Residing at least 4 nights per week in this home - Having given its agreement to carry out the research and the associated collection of biological samples, - and having signed the consent of the study (or its witness, or its legal representative if applicable) 2. for the anthropological study with interviews : 16 homes will be selected from among the 60 homes included: 8 homes in which the child has not acquired an ESBL-E during the entire follow-up and 8 homes in which the child has acquired an ESBL-E at least once during its follow-up. Among these households, interviews will be carried out with: 16 mothers or first responsible for the child in the absence of the mother 4 people with a mothering role on the child (grandmother, aunts ...) 4 minors in the families to observe 4 fathers or father figures in families to observe Also, interviews will be done with: Health actors: medical (1 midwife and 1 neighborhood doctor) and traditional (1 matron and 1 traditional practitioner from the neighborhood), 1 community health worker 1 neighborhood chief Inclusion criteria for semi-structured interviews : - people responding to the structuring functions of the child's social and family environment - Having given its agreement to carry out the research, - and having signed the consent of the study (or its witness, or its legal representative if applicable) For health workers and district managers, inclusion criteria for semi-structured interviews : - people responding to the targeted functions - working in the district of homes included - Having given its agreement to carry out the research, - and having signed the consent of the study (or its witness, or its legal representative if applicable) 3. For the anthropological study with observations 4 households in total among the 16 initially selected for the interviews: 2 households in which the child did not acquire ESBL-E during all the follow-up and 2 households in which the child acquired at least once an BLSE-E during his follow-up Inclusion criteria for participating direct observations - Residents of the same household as the mother-child (ren) couple included - having agreed to participate in the study - Having given its agreement to carry out the research, - and having signed the consent of the study (or its witness, or its legal representative if applicable) Exclusion Criteria: 1. For the epidemiological part: - Pregnant woman: non-monofetal pregnancy - Newborn: died during childbirth - Household resident: None 2. and 3) For the anthropological part: • Semi-structured interview: For household members: - not responding to the structural family and social functions of the child's environment For health workers and district managers - people not meeting the targeted functions - not practicing in the district of homes included • Participant direct observation: - Not living in the same household as the mother-child couple included |
Country | Name | City | State |
---|---|---|---|
Madagascar | Institut Pasteur de Madagascar | Antananarivo |
Lead Sponsor | Collaborator |
---|---|
Institut Pasteur | Centre hospitalier de référence du District de Moramanga, Institut Pasteur de Madagascar |
Madagascar,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Number of acquisition events and the number of non-acquisition of E-ESBL in newborns for the epidemiological part | Identification of bacterial strains from stool and sequencing of EBSL-E strains | 2 years | |
Primary | Number of semi-structured interviews completed for the anthropological part | 1 or 4 hours semi-structured interviews of participants at home done by investigators | 2 years | |
Primary | Number of participant direct observation completed for the anthropological part | observations of the participants at home done by investigators (2 to 4 hours in 3 to 4 sessions over 28 days) | 2 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02400268 -
Antibiotic Treatment Duration (7 vs 14 Days) Comparison in Blood Stream Infection Causes by Enterobacteriaceae
|
Phase 3 | |
Completed |
NCT03401242 -
Prevalence of ESBL and CPE in French Nursing Homes
|
||
Not yet recruiting |
NCT03967301 -
Prevention and Decolonization of Multidrug-resistant Bacteria With Probiotics
|
N/A | |
Completed |
NCT02795949 -
Study on Reduced Antibiotic Treatment vs Broad Spectrum Betalactam in Patients With Bacteremia by Enterobacteriaceae
|
Phase 3 | |
Completed |
NCT00573235 -
Epidemiology of Community - Associated Extended-spectrum Beta-lactamases (ESBL) Producing Escherichia Coli
|
||
Recruiting |
NCT00404625 -
Infections Caused by ESbL-Producing Enterobacteriaceae in Italy
|
N/A | |
Completed |
NCT00573521 -
Risk Factors for Piperacillin/Tazobactam Resistance in Extended-Spectrum Beta-Lactamase (ESBL) Producing Organisms
|
||
Recruiting |
NCT03671967 -
PipEracillin Tazobactam Versus mERoPENem for Treatment of Bloodstream Infections Caused by Cephalosporin-resistant Enterobacteriaceae (PETERPEN)
|
Phase 4 | |
Enrolling by invitation |
NCT03924934 -
Community-associated Highly-Resistant Enterobacterales
|
||
Completed |
NCT03477084 -
Understanding and Modeling Reservoirs, Vehicles and Transmission of ESBL-producing Enterobacteriaceae in the Community and Long Term Care Facilities
|
||
Not yet recruiting |
NCT05632315 -
PMT for MDRO Decolonization
|
Phase 2 | |
Withdrawn |
NCT03527056 -
Pilot Study Using Oral Capsule FMT to Decolonize GI CRE
|
Early Phase 1 | |
Completed |
NCT00826670 -
Enterobacteriaceae Producing Extended-spectrum β-lactamases (ESBL) Decolonization Study
|
Phase 4 | |
Not yet recruiting |
NCT04903886 -
Intensive Care Unit Acquired Infections in Patients Colonized With Extended Spectrum Enterobacteriaceae
|
||
Completed |
NCT02482051 -
Ultra Rapid Culture Independent Detection of High-Priority Carbapenem Resistant Enterobacteriaceae Directly From Blood
|
||
Recruiting |
NCT00894036 -
The Burden and Genetic Variability of Extended-Spectrum ß-Lactamase (ESBL) - Producing Pathogens in Swiss Children
|
N/A | |
Suspended |
NCT05355350 -
PipEracillin/Tazobactam Versus mERoPENem for Treatment of AmpC Producing Blood Stream Infections
|
Phase 4 | |
Recruiting |
NCT05516433 -
Effect of Imipenem and Meropenem on the Digestive Microbiota and the Emergence and Carriage of Multidrug-resistant Bacteria
|
||
Recruiting |
NCT02450942 -
18F-FDS PET/CT in Healthy Volunteers and Patients With Suspected Infection
|
Early Phase 1 | |
Recruiting |
NCT05035342 -
Fecal Transplantation to Eradicate Colonizing Emergent Superbugs
|
Phase 3 |